Spots Global Cancer Trial Database for amifostine trihydrate
Every month we try and update this database with for amifostine trihydrate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | NCT00003927 | Breast Cancer | filgrastim amifostine trih... cyclophosphamid... doxorubicin hyd... paclitaxel peripheral bloo... | 18 Years - 59 Years | City of Hope Medical Center | |
| Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome | NCT00005598 | Myelodysplastic... | amifostine trih... azacitidine | 18 Years - | University of Michigan Rogel Cancer Center | |
| Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome | NCT00003123 | Myelodysplastic... | amifostine trih... | 17 Years - | National Cancer Institute (NCI) | |
| High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer | NCT00003068 | Breast Cancer Drug/Agent Toxi... | amifostine trih... cyclophosphamid... mitoxantrone hy... thiotepa peripheral bloo... | 16 Years - 70 Years | National Cancer Institute (NCI) | |
| Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer | NCT00012012 | Cervical Cancer Radiation Toxic... | Amifostine trih... Cisplatin Intracavitary b... External beam r... | 18 Years - | Radiation Therapy Oncology Group | |
| Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome | NCT00003415 | Leukemia Myelodysplastic... | amifostine trih... topotecan hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00003268 | Drug/Agent Toxi... Leukemia | amifostine trih... cytarabine idarubicin | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer | NCT00003072 | Lung Cancer Neurotoxicity Ovarian Cancer | amifostine trih... carboplatin paclitaxel | 18 Years - | University of California, San Francisco | |
| Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer | NCT00040365 | Prostatic Neopl... | Amifostine trih... Radiation thera... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00006012 | Drug/Agent Toxi... Lung Cancer Radiation Toxic... | filgrastim amifostine trih... cisplatin etoposide paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy | NCT00003252 | Drug/Agent Toxi... Unspecified Adu... | amifostine trih... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | NCT00004919 | Unspecified Chi... | cisplatin irinotecan hydr... amifostine trih... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer | NCT00003777 | Head and Neck C... | amifostine trih... cisplatin fluorouracil surgical proced... radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer | NCT00003994 | Childhood Hepat... Recurrent Child... Stage I Childho... | therapeutic con... cisplatin vincristine sul... fluorouracil amifostine trih... carboplatin | - 21 Years | Children's Oncology Group | |
| Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | NCT00003251 | Drug/Agent Toxi... Head and Neck C... Radiation Toxic... | amifostine trih... cisplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer | NCT00003582 | Carcinoma of Un... Head and Neck C... | amifostine trih... cisplatin fluorouracil paclitaxel quality-of-life... radiation thera... | 18 Years - 120 Years | University of Miami | |
| S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer | NCT00003127 | Endometrial Can... | amifostine trih... carboplatin paclitaxel | 16 Years - | SWOG Cancer Research Network | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia | NCT00003405 | Leukemia | recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy... | 0 Years - 70 Years | Rush University Medical Center | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer | NCT00003136 | Ovarian Cancer Primary Periton... | filgrastim amifostine trih... carboplatin cyclophosphamid... peripheral bloo... | - 65 Years | University of Chicago | |
| Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy | NCT00004166 | Ovarian Cancer Quality of Life | amifostine trih... quality-of-life... | 18 Years - | Northwestern University | |
| Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome | NCT00005598 | Myelodysplastic... | amifostine trih... azacitidine | 18 Years - | University of Michigan Rogel Cancer Center | |
| Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00004176 | Drug/Agent Toxi... Lung Cancer Radiation Toxic... | amifostine trih... cisplatin etoposide radiation thera... | 18 Years - | Washington University School of Medicine | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia | NCT00003405 | Leukemia | recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy... | 0 Years - 70 Years | Rush University Medical Center | |
| Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer | NCT00003225 | Colorectal Canc... | amifostine trih... irinotecan hydr... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00003144 | Drug/Agent Toxi... Unspecified Adu... | amifostine trih... cisplatin gemcitabine hyd... | 18 Years - | NYU Langone Health | |
| Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome | NCT00003827 | Leukemia Myelodysplastic... | amifostine trih... cytarabine topotecan hydro... | 16 Years - | National Cancer Institute (NCI) | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer | NCT00003136 | Ovarian Cancer Primary Periton... | filgrastim amifostine trih... carboplatin cyclophosphamid... peripheral bloo... | - 65 Years | University of Chicago | |
| Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00003193 | Head and Neck C... Oral Complicati... | amifostine trih... paclitaxel conventional su... radiation thera... | 18 Years - | Massachusetts General Hospital | |
| Amifostine in Treating Patients With Myelodysplastic Syndrome | NCT00003048 | Myelodysplastic... | Amifostine Trih... | 18 Years - | M.D. Anderson Cancer Center | |
| Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003089 | Drug/Agent Toxi... Lung Cancer | amifostine trih... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML | NCT00003407 | Drug/Agent Toxi... Leukemia Myelodysplastic... Neutropenia | amifostine trih... cytarabine mitoxantrone hy... | 18 Years - 120 Years | Rush University Medical Center | |
| Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00003144 | Drug/Agent Toxi... Unspecified Adu... | amifostine trih... cisplatin gemcitabine hyd... | 18 Years - | NYU Langone Health | |
| Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome | NCT00003681 | Anemia Myelodysplastic... | epoetin alfa amifostine trih... | 18 Years - | National Cancer Institute (NCI) | |
| Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | NCT00003624 | Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma | amifostine trih... cisplatin paclitaxel | - | GOG Foundation | |
| Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia | NCT00503776 | Dysphagia Head and Neck C... Mucositis Xerostomia | exercise interv... amifostine trih... therapeutic die... | 21 Years - | Vanderbilt-Ingram Cancer Center | |
| Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | NCT00003583 | Drug/Agent Toxi... Lung Cancer Radiation Toxic... | amifostine trih... cisplatin etoposide radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer | NCT00058071 | Gestational Tro... Neurotoxicity Peripheral Neur... Unspecified Adu... | amifostine trih... | 18 Years - | GOG Foundation | |
| Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer | NCT00003225 | Colorectal Canc... | amifostine trih... irinotecan hydr... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | NCT00003624 | Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma | amifostine trih... cisplatin paclitaxel | - | GOG Foundation | |
| Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor | NCT00003211 | Brain and Centr... | filgrastim amifostine trih... cisplatin cyclophosphamid... vincristine sul... peripheral bloo... radiation thera... | 3 Years - 20 Years | St. Jude Children's Research Hospital | |
| Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00003193 | Head and Neck C... Oral Complicati... | amifostine trih... paclitaxel conventional su... radiation thera... | 18 Years - | Massachusetts General Hospital | |
| Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | NCT00003313 | Drug/Agent Toxi... Lung Cancer Oral Complicati... Radiation Toxic... | filgrastim amifostine trih... carboplatin paclitaxel radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma | NCT00217438 | Refractory Mult... Stage II Multip... Stage III Multi... | melphalan amifostine trih... peripheral bloo... fluorescence in... bone marrow abl... | 18 Years - 70 Years | Fred Hutchinson Cancer Center | |
| Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer | NCT00003307 | Prostate Cancer Radiation Toxic... | amifostine trih... radiation thera... | 18 Years - | University of Arizona | |
| Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003089 | Drug/Agent Toxi... Lung Cancer | amifostine trih... carboplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors | NCT00003811 | Childhood Germ ... Drug/Agent Toxi... Extragonadal Ge... Ovarian Cancer | bleomycin sulfa... amifostine trih... cisplatin etoposide conventional su... | - 14 Years | Children's Oncology Group | |
| Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome | NCT00003415 | Leukemia Myelodysplastic... | amifostine trih... topotecan hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer | NCT00006105 | Bladder Cancer Drug/Agent Toxi... | amifostine trih... cisplatin gemcitabine hyd... adjuvant therap... | 18 Years - | University of Chicago | |
| Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer | NCT00006105 | Bladder Cancer Drug/Agent Toxi... | amifostine trih... cisplatin gemcitabine hyd... adjuvant therap... | 18 Years - | University of Chicago | |
| Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer | NCT00003580 | Drug/Agent Toxi... Head and Neck C... Oral Complicati... Radiation Toxic... | amifostine trih... cisplatin radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome | NCT00003681 | Anemia Myelodysplastic... | epoetin alfa amifostine trih... | 18 Years - | National Cancer Institute (NCI) | |
| Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation | NCT00052884 | Drug/Agent Toxi... Multiple Myelom... | filgrastim amifostine trih... melphalan bone marrow abl... peripheral bloo... | 18 Years - 70 Years | Eastern Cooperative Oncology Group | |
| Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma | NCT00217438 | Refractory Mult... Stage II Multip... Stage III Multi... | melphalan amifostine trih... peripheral bloo... fluorescence in... bone marrow abl... | 18 Years - 70 Years | Fred Hutchinson Cancer Center | |
| Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx | NCT00025298 | Drug/Agent Toxi... Head and Neck C... Oral Complicati... Radiation Toxic... | amifostine trih... carboplatin cisplatin paclitaxel radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer | NCT00058071 | Gestational Tro... Neurotoxicity Peripheral Neur... Unspecified Adu... | amifostine trih... | 18 Years - | GOG Foundation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
